Market Cap (In GBp)
6.93 Million
Revenue (In GBp)
-
Net Income (In GBp)
-1717.00
Avg. Volume
1.09 Million
- Currency
- GBp
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.42-3.38
- PE
- -
- EPS
- -
- Beta Value
- 0.372
- ISIN
- GB00BNG2VN02
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Allan John Syms
- Employee Count
- -
- Website
- https://www.cizzlebiotechnology.com
- Ipo Date
- 2021-05-14
- Details
- Cizzle Biotechnology Holdings Plc engages in development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
More Stocks
-
DPBSF
-
SBSStratec SE
SBS
-
0QKRArbonia AG
0QKR
-
603496
-
034730SK Inc.
034730
-
013AJD.com, Inc.
013A
-
NDGPY
-
603038